davebridges
commented
9 years ago The missing two patients for whom we had phenotypic data but not RNAseq data were included in Figure 1 but not other analyses. This was described in the methods section:
These subjects corresponded to the patients described in Table 1, with the exception of subjects 29 and 31 (both acromegaly patients), which had clinical data but no RNAseq data.
It is neither clear why only 7 out of 9 patients were used for the study. In addition, the study lacks mechanistic studies and/or validations that confirms the direct action of GH on the analyzed genes.